Moneycontrol
HomeNewsBusinessZojila Tunnel Project will be completed by December 2023, earlier deadline 2026: Nitin Gadkari
Trending Topics

Zojila Tunnel Project will be completed by December 2023, earlier deadline 2026: Nitin Gadkari

The minister today visited the Zojila in theUnion Terriotary of Jammu & Kashmir and directed the authorities of Megha Engineering and Infrastructures, the company involved in the construction of the tunnel, to complete the tunnel before the 2024 parliamentary election.

September 28, 2021 / 17:49 IST
Story continues below Advertisement

Union Minister for Road Transport and Highways Nitin Gadkari on September 28 said that the strategic Zojila Tunnel Project will be completed by December 2023, much before its earlier deadline of 2026.

The minister visited the Zojila in the Union Territory of Jammu & Kashmir and directed the authorities of Megha Engineering and Infrastructures, the company involved in the construction of the tunnel, to complete the tunnel before the 2024 parliamentary election.

Story continues below Advertisement

“I am satisfied with the speed of the construction and have told the authorities to complete the construction of the approaching tunnels before May 2024, so that we can show the opposition that we have achieved,” Gadkari said, while addressing a press conference after inspecting work progress on Zojila and Z-Morh tunnel.

The union minister added that projects worth Rs 1 lakh crore are currently being implemented in Jammu and Kashmir.
“Among all the projects, six of them are the most important ones for the socio-economic development of Jammu and Kashmir,” he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show